TrialEuropean journal of medical research2025

Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties: a randomized controlled trial.

Andreja Rehberger Likozar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.